(Q33357118)

26 July 2017

title

Everolimus in de novo cardiac transplantation: pharmacokinetics, therapeutic range, and influence on cyclosporine exposure (English)

1 reference

26 July 2017

1 reference

1 reference

4

Donna Mancini

1 reference

26 July 2017

John M Kovarik

1

1 reference

26 July 2017

Howard Eisen

2

1 reference

26 July 2017

Richard Dorent

3

1 reference

26 July 2017

Mario Vigano

5

1 reference

26 July 2017

Marisel Rouilly

6

1 reference

26 July 2017

Chyi-Hung Hsu

7

1 reference

26 July 2017

Christiane Rordorf

8

1 reference

26 July 2017

publication date

1 October 2003

1 reference

The Journal of Heart and Lung Transplantation

26 July 2017

published in

1 reference

26 July 2017

volume

22

1 reference

26 July 2017

issue

10

1 reference

26 July 2017

page(s)

1117-1125

1 reference

The role of Certican (everolimus, rad) in the many pathways of chronic rejection

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901221-4

7 January 2021

Longitudinal assessment of everolimus in de novo renal transplant recipients over the first post-transplant year: pharmacokinetics, exposure-response relationships, and influence on cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901221-4

7 January 2021

A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailability

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901221-4

7 January 2021

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901221-4

7 January 2021

On the statistical analysis of ROC curves

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901221-4

7 January 2021

Exposure-response relationships for everolimus in de novo kidney transplantation: defining a therapeutic range

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901221-4

7 January 2021

Evidence for earlier stabilization of cyclosporine pharmacokinetics in de novo renal transplant patients receiving a microemulsion formulation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901221-4

7 January 2021

Sirolimus-induced thrombocytopenia and leukopenia in renal transplant recipients: risk factors, incidence, progression, and management

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901221-4

7 January 2021

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901221-4

7 January 2021

RAD in de novo renal transplantation: comparison of three doses on the incidence and severity of acute rejection

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901221-4

7 January 2021

10.1016/S1053-2498(02)01221-4

Identifiers

DOI

1 reference

26 July 2017

1 reference